Jørstad S, Smeby L C, Balstad T, Widerøe T E
Department of Medicine, University of Trondheim, Norway.
Blood Purif. 1988;6(6):325-35. doi: 10.1159/000169561.
The generation of anaphylatoxins (C3a and C5a) during hemofiltration with polysulfone (F60), acrylonitrile (AN69 HF), polyamid (FH77), polyacrylonitrile (PAN200) and cellulose-acetate (Duo-Flux) membranes were investigated. The 'net' production of C3a in the blood compartment during the treatment was 3,028 micrograms (Duo-Flux), 1,845 micrograms (FH77), 270 micrograms (F60), -2,388 micrograms (AN69 HF) and -5,189 micrograms (PAN200), the latter two negative values reflecting a high adsorption of C3a to the membrane material. Corresponding values for C5a were 185 micrograms (AN69 HF), 108 micrograms (F60), 83 micrograms (PAN200), 6 micrograms (FH77) and -133 micrograms (Duo-Flux). The sieving coefficient remained stable for C5a throughout the treatment, while it fell significantly for C3a with the F60 membrane (0.44-0.25) and increased significantly for the FH77 membrane (0.14-0.33). The cellulose-acetate membrane device produced the most pronounced drop in white blood cell counts and the acrylonitrile membrane the least. The Duo-Flux device was significantly less biocompatible than the other membranes investigated, while little differences were found between AN69 HF, F60, FH77 and PAN200. When hemodialysis is compared with hemofiltration employing the same membranes, the latter appears to be a more biocompatible treatment modality partly due to convective removal of activated complement from the blood compartment into the filtrate.
研究了使用聚砜(F60)、丙烯腈(AN69 HF)、聚酰胺(FH77)、聚丙烯腈(PAN200)和醋酸纤维素(Duo-Flux)膜进行血液滤过期间过敏毒素(C3a和C5a)的生成情况。治疗期间血液腔室中C3a的“净”产量分别为3028微克(Duo-Flux)、1845微克(FH77)、270微克(F60)、-2388微克(AN69 HF)和-5189微克(PAN200),后两个负值反映了C3a对膜材料的高吸附性。C5a的相应值分别为185微克(AN69 HF)、108微克(F60)、83微克(PAN200)、6微克(FH77)和-133微克(Duo-Flux)。在整个治疗过程中,C5a的筛系数保持稳定,而F60膜的C3a筛系数显著下降(从0.44降至0.25),FH77膜的C3a筛系数显著增加(从0.14增至0.33)。醋酸纤维素膜装置导致白细胞计数下降最为明显,丙烯腈膜导致的下降最少。Duo-Flux装置的生物相容性明显低于所研究的其他膜,而AN69 HF、F60、FH77和PAN200之间的差异很小。当将血液透析与使用相同膜的血液滤过进行比较时,后者似乎是一种生物相容性更好的治疗方式,部分原因是通过对流将活化补体从血液腔室清除到滤液中。